BioCentury
ARTICLE | Company News

ComGenex, Echelon Biosciences Inc. deal

November 1, 2004 8:00 AM UTC

The companies expanded a 2002 deal to develop therapeutics to treat cancer, cardiovascular and inflammatory diseases (see BioCentury, Feb. 4, 2002). Echelon now has the right to acquire ComGenex's sha...